Clinical Trials on Cutaneous T Cell Lymphomas (CTCL) in Japan
Total 171 results
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)Japan
-
NovartisCompletedCutaneous T-Cell Lymphoma | TumorsJapan
-
Eisai Inc.CompletedLymphoma, T-cell, Peripheral | Lymphoma, T-cell, CutaneousJapan
-
Novartis PharmaceuticalsTerminatedLeukemia-Lymphoma, Adult T-Cell | Cutaneous T-Cell LymphomaJapan
-
Kyowa Kirin Co., Ltd.CompletedAdult T-Cell Leukemia and Lymphoma (ATL) | Adult Peripheral T-Cell Lymphoma (PTCL)Japan
-
Eisai Co., Ltd.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaJapan
-
HUYABIO International, LLC.Quintiles, Inc.CompletedPeripheral T-Cell Lymphoma (PTCL)Japan, Korea, Republic of
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Mundipharma K.K.CompletedRecurrent or Refractory PTCLJapan
-
TakedaCompletedPeripheral T Cell Lymphoma | Pediatric Hodgkin LymphomaJapan
-
CelgeneCompletedPeripheral T-cell Lymphoma | Adult T-cell Leukemia-LymphomaJapan
-
Bristol-Myers SquibbRecruitingPeripheral T-cell LymphomaJapan
-
Mundipharma K.K.CompletedPeripheral T-cell LymphomaJapan
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
CelgeneCompletedLymphoma, T-Cell, PeripheralJapan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Solasia Pharma K.K.CompletedPeripheral T-cell LymphomaJapan
-
Kyowa Kirin Co., Ltd.CompletedAdult T-cell Leukemia-lymphomaJapan
-
HUYABIO International, LLC.Quintiles, Inc.CompletedAdult T-Cell Lymphoma (ATL)Japan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompleted
-
Kyowa Kirin Co., Ltd.CompletedPeripheral T/NK-cell LymphomaJapan
-
Kyowa Kirin Co., Ltd.CompletedAdult T-cell Leukemia-LymphomaJapan
-
National Cancer Institute (NCI)CompletedHuman T-Lymphoma Virus Type IUnited States, Jamaica, Japan
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
CelgeneActive, not recruiting
-
CelgeneCompleted
-
Daiichi SankyoActive, not recruitingRelapsed/Refractory Peripheral T-Cell Lymphoma | Adult T Cell Leukemia/LymphomaUnited States, Spain, Japan, United Kingdom, Korea, Republic of, France, Italy, Australia, Canada, Germany, Netherlands, Taiwan
-
Solasia Pharma K.K.CompletedPeripheral T-Cell LymphomaHong Kong, Japan, Taiwan, Korea, Republic of
-
Stanford UniversityRecruitingNon-Hodgkin's Lymphoma | Mycosis FungoidesUnited States, China, Argentina, Australia, Brazil, Japan, United Kingdom
-
CelgeneCompletedAdult T-Cell Leukemia-LymphomaJapan
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Daiichi Sankyo Co., Ltd.Active, not recruitingAdult T-cell Leukemia/LymphomaJapan
-
4SC AGActive, not recruitingLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeAustria, Spain, Germany, United Kingdom, France, Belgium, Japan, Switzerland, Italy, Poland, Netherlands, Greece
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaJapan
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
Jichi Medical UniversityTakara Bio Inc.UnknownRelapsed or Refractory B-Cell Non-Hodgkin LymphomaJapan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Janssen Pharmaceutical K.K.Completed
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
Hiroshima University HospitalRecruitingAggressive NK Cell LeukemiaJapan
-
Incyte CorporationCompleted
-
Janssen Pharmaceutical K.K.Pharmacyclics LLC.CompletedRecurrent Mature B-cell NeoplasmsJapan
-
SymBio PharmaceuticalsCompletedLow-grade B Cell Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not IndicatedJapan
-
PfizerCompleted
-
PfizerHoffmann-La RocheRecruitingDiffuse Large B-Cell LymphomaTaiwan, United States, Japan